Lensiprazine, identified by its CAS number 327026-93-7, is a chemical compound that belongs to the class of drugs known as serotonin and norepinephrine reuptake inhibitors (SNRIs). It is primarily investigated for its potential use in treating mood disorders, particularly depression and anxiety. The compound exhibits a unique mechanism of action by modulating neurotransmitter levels in the brain, which can help improve mood and emotional well-being. Lensiprazine is characterized by its ability to selectively inhibit the reuptake of serotonin and norepinephrine, leading to increased availability of these neurotransmitters in the synaptic cleft. This pharmacological profile suggests that it may have a favorable side effect profile compared to traditional antidepressants. Additionally, Lensiprazine has been studied for its effects on cognitive function and its potential neuroprotective properties. As with any pharmacological agent, further research is necessary to fully understand its efficacy, safety, and long-term effects in clinical settings.

Lensiprazine

327026-93-7: Lensiprazine, identified by its CAS number 327026-93-7, is a chemical compound that belongs to the class of drugs known as serotonin and norepinephrine reuptake inhibitors (SNRIs). It is primarily investigated for its potential use in treating mood disorders, particularly depression and anxiety. The compound exhibits a unique mechanism of action by modulating neurotransmitter levels in the brain, which can help improve mood and emotional well-being. Lensiprazine is characterized by its ability to selectively inhibit the reuptake of serotonin and norepinephrine, leading to increased availability of these neurotransmitters in the synaptic cleft. This pharmacological profile suggests that it may have a favorable side effect profile compared to traditional antidepressants. Additionally, Lensiprazine has been studied for its effects on cognitive function and its potential neuroprotective properties. As with any pharmacological agent, further research is necessary to fully understand its efficacy, safety, and long-term effects in clinical settings.

Lensiprazine (SLV314) is a potent dopamine D(2) receptor antagonist that acts as a serotonin reuptake inhibitor , and can be used to study bipolar disorder and

CAS 327026-93-7

Lensiprazine

Lensiprazine

Ref: 54-BUP03677

Lensiprazine

Ref: TM-T32633